Disease | renal cell carcinoma |
Phenotype | C0022116|ischemia |
Sentences | 2 |
PubMedID- 23818962 | But bevacizumab was not found to significantly increase the risk of cardiac ischemia in patients with renal cell carcinoma or liver cancer in comparison with controls (rr, 6.12; 95% ci, 0.83–45.34; rr, 4.57; 95% ci, 0.19–107.29). |
PubMedID- 25943322 | Purpose: the objective of this study is to evaluate the relationship of atheroembolic risk factors with postoperative recovery of renal function after on-clamp partial nephrectomy (pn) with warm ischemia in patients with staged t1-2 renal cell carcinoma (rcc). |
Page: 1